FIELD: applied virology, medicinal genetics. SUBSTANCE: the present innovation deals with single bioinformation-type approach to the impact upon body to remove pathogens representing both classical viruses, such as herpes, HIV, hepatitis B and C viruses, etc and nonstandard ones such as priones. Impact consists of two stages: removal of pathogen at individual consideration for viral replication peculiarities in target cells of immunosystem followed by extracorporal treatment, restoration of immunoinformation relations due to transplantation of morphological elements out of placental-funicular blood. The present innovation, also, deals with the method to prepare laboratory animal to be used for testing such a method of impact upon body in case of slow viral infection. EFFECT: more accurate individualization of approach. 12 cl, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATMENT OF PATIENT WITH HIV-INFECTION | 1998 |
|
RU2146930C1 |
METHOD OF TREATING AUTOIMMUNE DEFICIENCY SYNDROME (AIDS) | 1995 |
|
RU2105310C1 |
METHOD OF THERAPEUTIC INFLUENCE ON HIV-INFECTED AND PATIENTS WITH AIDS | 2007 |
|
RU2359719C2 |
METHOD FOR TREATMENT OF AIDS | 2004 |
|
RU2285529C2 |
METHOD OF THERAPEUTIC INFLUENCE ON PERSONS INFECTED WITH VIRUS OF HERPES | 2007 |
|
RU2359720C2 |
METHOD FOR SUPPRESSING HIV-INFECTION | 1999 |
|
RU2198664C2 |
RECESSIVE DIVIDING RETROVIRAL VECTOR (VARIANTS), METHOD FOR PRODUCTION THEREOF (VARIANTS), ISOLATED AND PURIFIED NUCLEIC ACID MOLECULE | 1996 |
|
RU2270250C2 |
ANTI-VIRAL AGENT | 2006 |
|
RU2316320C1 |
METHOD FOR TREATING HIV-INFECTION | 2010 |
|
RU2449818C1 |
METHOD OF INHIBITING HIV REPLICATION IN CELLS OF MAMMALS AND HUMANS | 2011 |
|
RU2593948C2 |
Authors
Dates
2003-07-10—Published
2001-11-08—Filed